Oncology and Hematology - Global Oncology Academy

257-272 of 663

Personalized Treatment Pathways in Endometrial Cancer: A Molecular Approach
Personalized Treatment Pathways in Endometrial Cancer: A Molecular Approach
Project Oncology®
Personalized Treatment Pathways in Endometrial Cancer: A Molecular Approach
Kathleen Moore, MD, MS
- Kathleen Moore, MD, MS
Subcutaneous Isatuximab Matches IV in Multiple Myeloma: Insights from IRAKLIA
Subcutaneous Isatuximab Matches IV in Multiple Myeloma: Insights from IRAKLIA
Project Oncology®
Subcutaneous Isatuximab Matches IV in Multiple Myeloma: Insights from IRAKLIA
Marlene Mimi Maeusli, PhD.
- Marlene Mimi Maeusli, PhD.
Navigating Fertility Preservation in Young Patients With Endometrial Cancer
Navigating Fertility Preservation in Young Patients With Endometrial Cancer
Project Oncology®
Navigating Fertility Preservation in Young Patients With Endometrial Cancer
Kathleen Moore, MD, MS
- Kathleen Moore, MD, MS
Rewriting the Prognosis: Advances in Endometrial Cancer Diagnosis and Treatment
Rewriting the Prognosis: Advances in Endometrial Cancer Diagnosis and Treatment
Project Oncology®
Rewriting the Prognosis: Advances in Endometrial Cancer Diagnosis and Treatment
Kathleen Moore, MD, MS
- Kathleen Moore, MD, MS
Redefining Cancer Care with Functional Precision Medicine
Redefining Cancer Care with Functional Precision Medicine
Project Oncology®
Redefining Cancer Care with Functional Precision Medicine
Matt Birnholz, MD; Jim Foote, MBA
- Matt Birnholz, MD
- Jim Foote, MBA
Patient Perspectives on Subcutaneous vs IV Immunotherapies in Oncology Care
Patient Perspectives on Subcutaneous vs IV Immunotherapies in Oncology Care
Project Oncology®
Patient Perspectives on Subcutaneous vs IV Immunotherapies in Oncology Care
Ryan Quigley
- Ryan Quigley
From Infusion to Injection: Can Subcutaneous Delivery Match Intravenous Standards in Oncology?
From Infusion to Injection: Can Subcutaneous Delivery Match Intravenous Standards in Oncology?
Project Oncology®
From Infusion to Injection: Can Subcutaneous Delivery Match Intravenous Standards in Oncology?
Are Subcutaneous Immunotherapies Expanding Access and Efficiency in Cancer Care?
Are Subcutaneous Immunotherapies Expanding Access and Efficiency in Cancer Care?
Project Oncology®
Are Subcutaneous Immunotherapies Expanding Access and Efficiency in Cancer Care?
Ryan Quigley
- Ryan Quigley
Advancing Endometrial Cancer Care: ADCs and Biomarker-Based Therapies
Advancing Endometrial Cancer Care: ADCs and Biomarker-Based Therapies
Project Oncology®
Advancing Endometrial Cancer Care: ADCs and Biomarker-Based Therapies
Brian Slomovitz, MD
- Brian Slomovitz, MD
From Infusion Chair to Clinic Visit: How Subcutaneous Nivolumab May Simplify RCC Care
From Infusion Chair to Clinic Visit: How Subcutaneous Nivolumab May Simplify RCC Care
Project Oncology®
From Infusion Chair to Clinic Visit: How Subcutaneous Nivolumab May Simplify RCC Care
Subcutaneous Pembrolizumab in mNSCLC: A Potential Shift in the Delivery Landscape
Subcutaneous Pembrolizumab in mNSCLC: A Potential Shift in the Delivery Landscape
Project Oncology®
Subcutaneous Pembrolizumab in mNSCLC: A Potential Shift in the Delivery Landscape
Redefining First-Line Treatment in Endometrial Cancer: The Role of Immunotherapy
Redefining First-Line Treatment in Endometrial Cancer: The Role of Immunotherapy
Project Oncology®
Redefining First-Line Treatment in Endometrial Cancer: The Role of Immunotherapy
Brian Slomovitz, MD
- Brian Slomovitz, MD
Putting Patients First: Personalized Care in Metastatic Breast Cancer
Putting Patients First: Personalized Care in Metastatic Breast Cancer
On the Frontlines of Metastatic Breast Cancer
Putting Patients First: Personalized Care in Metastatic Breast Cancer
Ashley Baker, MSN, PMHNP; Giancarlo Moscol, M.D.
- Ashley Baker, MSN, PMHNP
- Giancarlo Moscol, M.D.
Emerging and Practice Changing Data in Immunotherapy Strategies for Melanoma
Emerging and Practice Changing Data in Immunotherapy Strategies for Melanoma
MinuteCE®
Emerging and Practice Changing Data in Immunotherapy Strategies for Melanoma
Sapna Patel, MD; John M. Kirkwood, MD
1.00 program credit
- Sapna Patel, MD
- John M. Kirkwood, MD
1.00 program credit
MinuteCE®
Reimagining Lung Cancer Treatment: A Journey Through New and Emerging Therapeutics Related to the Care of Patients with Small Cell and Non-Small Cell Lung Cancer
Stephen Liu, MD; Joshua K. Sabari, MD
1.25 credits 9 episodes
- Stephen Liu, MD
- Joshua K. Sabari, MD
- Susan Scott, MD
1.25 credits 9 episodes
HER2-Driven Strategies in Metastatic NSCLC
HER2-Driven Strategies in Metastatic NSCLC
MinuteCE®
HER2-Driven Strategies in Metastatic NSCLC
Stephen Liu, MD; Joshua K. Sabari, MD
1.25 program credits
- Stephen Liu, MD
- Joshua K. Sabari, MD
- Susan Scott, MD
1.25 program credits

17/11